Management uses adjusted operating results to monitor and evaluate performance of the company's business segments. Results in the following segment information are reported on a pro forma adjusted basis for 2006, as if Thermo and Fisher had been combined for the entire year.
Analytical Technologies Segment
Revenues in the Analytical Technologies Segment grew 12% in the third quarter of 2007 to $1.04 billion, compared with pro forma 2006 revenues of $931 million. Operating income increased 26% in the third quarter of 2007, and operating margin rose to 19.4%, versus pro forma 2006 results of 17.3%.
Laboratory Products and Services Segment
In the Laboratory Products and Services Segment, revenues grew 4% in the third quarter of 2007 to $1.45 billion, compared with pro forma 2006 revenues of $1.39 billion. Operating income increased 10% in the third quarter of 2007, and operating margin rose to 14.0%, versus pro forma 2006 results of 13.3%.
Use of Non-GAAP Financial Measures
In addition to the financial measures prepared in accordance with
generally accepted accounting principles (GAAP), we use certain non-GAAP
financial measures, including adjusted EPS, adjusted operating income and
adjusted operating margin, which exclude restructuring and other
costs/income and amortization of acquisition-related intangible assets.
Adjusted EPS also excludes certain oth
|SOURCE Thermo Fisher Scientific Inc.|
Copyright©2007 PR Newswire.
All rights reserved